Diagnostics News and Research

RSS

ß-Hydroxybutyrate LiquiColor® reagent system to detect ketosis

Stanbio Laboratory, an EKF company, has developed the ß-Hydroxybutyrate LiquiColor® Reagent System to improve the detection of clinically significant ketosis.

From EKF Diagnostics 7 Jan 2016

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

Royal Philips and Banyan Biomarkers, Inc. today announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care.

From Philips Healthcare 7 Jan 2016

“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

EKF Diagnostics, the global in vitro diagnostics company, announces the publication of its new guide, “Anemia and hemoglobin testing” .

From EKF Diagnostics 7 Jan 2016

Avalon Healthcare Solutions receives additional investment from Francisco Partners

Avalon Healthcare Solutions today announced a second round of investment from Francisco Partners. The incremental capital will be used to enhance Avalon's comprehensive laboratory management technology and clinical capabilities, as well as to strengthen growth opportunities.

7 Jan 2016

Biocept introduces blood-based test for detection, monitoring of prostate cancer and breast cancer

Biocept, Inc., a molecular diagnostics company commercializing and developing biomarkers to improve the detection and treatment of cancer, announces the launch of the CLIA-validated androgen receptor expression assay using a patient's blood for the detection and monitoring of late-stage prostate cancer and a certain form of breast cancer.

7 Jan 2016

Scientists find genetic link to unexplained heart failure affecting pregnant women

Scientists have found that women who suffer unexplained heart failure towards the end of pregnancy or shortly after giving birth share certain genetic changes.

7 Jan 2016

MGC Diagnostics' total revenues grow 24.9% to $37.5 million in fiscal year 2015

MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the fourth quarter and the fiscal year 2015, ended October 31, 2015.

6 Jan 2016

Good bacteria can help inhibit growth of S. pneumoniae

A new study from the Forsyth Institute is helping to shed more light on the important connections among the diverse bacteria in our microbiome. According to research published in mBio, scientists at Forsyth, led by Dr. Katherine P. Lemon, along with their collaborator at Vanderbilt University, have demonstrated that a harmless bacterium found in the nose and on skin may negatively impact the growth of a pathogen that commonly causes middle ear infections in children and pneumonia in children and older adults.

6 Jan 2016

Study reveals promising mechanism for attacking Ebola virus

In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.

5 Jan 2016

New tests could improve diagnosis of two rare childhood diseases

For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.

5 Jan 2016

High diversity among circulating tumor cells predicts survival, treatment resistance in prostate cancer patients

Research teams at Memorial Sloan Kettering Cancer Center and Epic Sciences have found that greater diversity among circulating tumor cells (CTCs) in the blood of advanced prostate cancer patients predicts not only shorter overall survival, but also the development of resistance to key anti-androgen therapies.

4 Jan 2016

New study describes STING protein's role in potential suppression of colorectal cancer

A new study published today by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine reports on a key finding about the immune system's response to tumor development following studies on colorectal cancer.

4 Jan 2016

Parents could make a difference in reducing teen violence, study finds

Nearly one-fourth of all teens reported being involved in a physical fight in the past year, with higher rates of violent altercations among African American and Latino adolescents. In the first study of its kind, researchers conducted focus groups with African American and Latino parents regarding teen violence.

31 Dec 2015

Nestlé Health Science recognizes Christelle Leiker with OPTIFAST "INSPIRE" award

Nestlé Health Science today recognized Christelle Leiker, Certified Nurse Practitioner, for her unwavering commitment to promoting the health and well-being of her patients. Christelle practices at the Texas Center for Obesity and General Surgery, where she runs the nonsurgical weight management program.

31 Dec 2015

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Amarantus BioScience Holdings, Inc., a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the US Food and Drug Administration to treat GCMN with Engineered Skin Substitute (ESS).

30 Dec 2015

Newly discovered molecular mechanism may provide alternative explanation for antibiotic resistance

The bacterium B. cereus had so far been considered to be exclusively endospore-forming. In response to harsh conditions, the bacteria form protective endospores enabling them to remain dormant for extended periods. When conditions are more favourable, the endospores reactivate to become fully functioning bacteria.

28 Dec 2015

Ebola virus and bats waging molecular battle for survival

Ebola virus and bats have been waging a molecular battle for survival that may have started at least 25 million years ago, according to a study led by researchers at Albert Einstein College of Medicine, the University of Colorado-Boulder (CU-Boulder) and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) that published online today in the journal eLife.

24 Dec 2015

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.

24 Dec 2015

Researchers, patients trade new insights at International Dementia with Lewy Bodies Conference

You thought Alzheimer's was complicated? Or Parkinson's? Try dementia with Lewy bodies, the disease occupying the awkward territory between those two poles.

23 Dec 2015

Biocept agrees $15 million common stock purchase deal with Aspire

Biocept, Inc., a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the detection, monitoring and treatment of cancer, announces a $15 million common stock purchase agreement with Aspire Capital Fund, LLC, a Chicago-based institutional investor.

22 Dec 2015

Diagnostics News and Research

ß-Hydroxybutyrate LiquiColor® reagent system to detect ketosis

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

Avalon Healthcare Solutions receives additional investment from Francisco Partners

Biocept introduces blood-based test for detection, monitoring of prostate cancer and breast cancer

Scientists find genetic link to unexplained heart failure affecting pregnant women

MGC Diagnostics' total revenues grow 24.9% to $37.5 million in fiscal year 2015

Good bacteria can help inhibit growth of S. pneumoniae

Study reveals promising mechanism for attacking Ebola virus

New tests could improve diagnosis of two rare childhood diseases

High diversity among circulating tumor cells predicts survival, treatment resistance in prostate cancer patients

New study describes STING protein's role in potential suppression of colorectal cancer

Parents could make a difference in reducing teen violence, study finds

Nestlé Health Science recognizes Christelle Leiker with OPTIFAST "INSPIRE" award

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Newly discovered molecular mechanism may provide alternative explanation for antibiotic resistance

Ebola virus and bats waging molecular battle for survival

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

Researchers, patients trade new insights at International Dementia with Lewy Bodies Conference

Biocept agrees $15 million common stock purchase deal with Aspire

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News